Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients (EXSUFLOW)
Primary Purpose
Neuromuscular Diseases
Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Objective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
Subjective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
Sponsored by
About this trial
This is an interventional treatment trial for Neuromuscular Diseases focused on measuring Neuromuscular disease
Eligibility Criteria
Inclusion Criteria:
- Aged ≥18 years
- Neuromuscular pathology
- Coughing aid information: DEPT <180 l / min
- In stable condition and without bulk
- Good understanding and cognition to follow the instructions and to inform the EVA
- Affiliated to a Sickness Insurance Plan or entitled
- Signed of informed consent
Exclusion Criteria:
- Pregnant woman
- Person under guardianship
- Inability to cooperate and / or communicate
- Acute decompensated organ
Patient with following contraindications to mechanical in-exsufflation (MI-E) devices:
- pneumothorax
- pneumomediastinum
- pulmonary emphysema
- hemoptysis
- pleurisy
- nausea
- obstructive pulmonary disease or asthma
- recent lobectomy of the lung
- intracranial pressure
Sites / Locations
- Department of Physiology and Functional Explorations, Raymond Poincaré Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Objective adjustment of the MI/E exsuflation pressure
Subjective adjustment of the MI/E exsuflation pressure
Arm Description
Objective adjustment of the MI/E exsuflation pressure based on the flow-volume curve generated during the cough.
Subjective adjustment of the MI/E exsuflation pressure based on the clinical judgment of the therapist and the patient.
Outcomes
Primary Outcome Measures
Area Under Curve (AUC) Flow Volume
The primary endpoint is the Area Under Curve (AUC) Flow Volume during the cough expiratory phase.
To compare the cough effectiveness obtained according to the current modalities of the MI / E exsuflation pressure setting to that resulting from an adjustment based on the analysis of the flow-volume curve.
Secondary Outcome Measures
Peak Cough Flow (PCF)
The Peak Cough Flow (PCF) : will be measured with a spirometer connected in series on the circuit of MI-E. Will be checked: whether the best AUC and the best PCF (regardless of the modality) occur during the same level of depression.
Evaluate the association between the peak cough flow (PCF) generated and the subjective criteria
Subjective Therapist Cough Effectiveness
These measurements will be performed using an Analogical Visual Scale.
Subjective Patient Cough Effectiveness
These measurements will be performed using an Analogical Visual Scale.
Respiratory comfort
The respiratory comfort of the patient during the effort of cough. These measurements will be performed using an Analogical Visual Scale.
Full Information
NCT ID
NCT03355105
First Posted
November 22, 2017
Last Updated
August 11, 2022
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT03355105
Brief Title
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
Acronym
EXSUFLOW
Official Title
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 7, 2019 (Actual)
Primary Completion Date
October 24, 2022 (Anticipated)
Study Completion Date
October 24, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In the context of neuromuscular diseases, the weakness of the respiratory muscles makes difficult to manage periods of congestion due to a less effective cough. It exposes the patient to bronchial superinfections that may require hospitalization. The use of cough assistance is therefore essential in order to avoid acute situations such as bronchial superinfections. Mechanical Insuflation-Exsufflation (MI / E) is an instrumental technique commonly used by therapists in a hospital or at the patient's home in order to facilitate the airway mucus clearance. The choice of the pressure settings of the IM / E is a decisive point because it conditions the effectiveness of the generated cough. It'is important to take into account the presence of any collapse in the use of IM / E in order to ensure the most effective cough given by the patient. Actually, except the common impression of the physiotherapist and the patient, there is no "simple" way for detecting and objectifying the threshold of collapse in the upper airways.
The aim of this study is to compare two modalities for the regulation of the level of the MI-E exsufflation, taking into account the presence of a collapse: a subjective "S" adjustment based on the clinical judgment of the therapist and the patient and an objective "O" adjustment based on the flow-volume curve generated during the cough.
Detailed Description
This is a bicentric, prospective crossover, randomized, open label trial. The study will focus on 50 adult patients with stable neuromuscular conditions, outside the congestion period requiring cough help.
Patients will be recruited from among the neuromuscular disease patients followed for their respiratory management in the home ventilation unit of the Raymond Poincaré Hospital Intensive care Unit or in the Aincourt Neurological Rehabilitation Service attached to the Vexin Intercommunal Hospital Group.
The cough help performed with the MI / E will be evaluated according to two conditions of adjustment of the exsufflation pressure: a subjective adjustment (modality S) and an objective adjustment (modality O), whose order will be randomized to control a phenomenon of tiredness causing confusion.
A respiratory technician and two therapists will participate to the protocol. The therapist "clinician" and "evaluator" role will be defined by a draw.
The protocol will take place during the same day of hospitalization in two stages:
T0: validation of the eligibility criteria and inclusion of patients in the study.
T1: evaluation of coughing performance according to the two modes of exsufflation pressure adjustment. Adjustment modality "S" according to the clinical impression of the "clinician" therapist and the patient, and the "Cough Peak Expiratory Flow" measured by the MI / E. Adjustment modality "O": according to the analysis of the flow / volume curve measured using a spirometer and a pneumotachograph.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Diseases
Keywords
Neuromuscular disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
29 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Objective adjustment of the MI/E exsuflation pressure
Arm Type
Experimental
Arm Description
Objective adjustment of the MI/E exsuflation pressure based on the flow-volume curve generated during the cough.
Arm Title
Subjective adjustment of the MI/E exsuflation pressure
Arm Type
Active Comparator
Arm Description
Subjective adjustment of the MI/E exsuflation pressure based on the clinical judgment of the therapist and the patient.
Intervention Type
Other
Intervention Name(s)
Objective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
Intervention Description
The exsufflation pressures will be progressively increased starting from -20 cmH2O with 10 cmH2O increments up. 3 coughing operations will be realised for each level, until obtention of 10% of AUC decrease or a PCF collapse of at least 10% over the last 2 levels and without exceeding -70 cmH2O. The selected landing will be the one allowing the largest PCF without presence of collapse. An intermediate bearing between 2 bearings may be tested in order to approach an optimum adjustment threshold less than 5 cmH2O.
Intervention Type
Other
Intervention Name(s)
Subjective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
Intervention Description
The exsufflation pressures will be gradually increased from -20 cmH2O, with 10 cmH2O increments up to a maximum of -70 cmH2O. The selected level will be the one selected both by the patient and the "clinician" therapist and considered as making it possible to obtain the most effective cough according to the return of the patient.
Primary Outcome Measure Information:
Title
Area Under Curve (AUC) Flow Volume
Description
The primary endpoint is the Area Under Curve (AUC) Flow Volume during the cough expiratory phase.
To compare the cough effectiveness obtained according to the current modalities of the MI / E exsuflation pressure setting to that resulting from an adjustment based on the analysis of the flow-volume curve.
Time Frame
At baseline
Secondary Outcome Measure Information:
Title
Peak Cough Flow (PCF)
Description
The Peak Cough Flow (PCF) : will be measured with a spirometer connected in series on the circuit of MI-E. Will be checked: whether the best AUC and the best PCF (regardless of the modality) occur during the same level of depression.
Time Frame
At baseline
Title
Evaluate the association between the peak cough flow (PCF) generated and the subjective criteria
Time Frame
At baseline
Title
Subjective Therapist Cough Effectiveness
Description
These measurements will be performed using an Analogical Visual Scale.
Time Frame
At baseline
Title
Subjective Patient Cough Effectiveness
Description
These measurements will be performed using an Analogical Visual Scale.
Time Frame
At baseline
Title
Respiratory comfort
Description
The respiratory comfort of the patient during the effort of cough. These measurements will be performed using an Analogical Visual Scale.
Time Frame
At baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged ≥18 years
Neuromuscular pathology
Coughing aid information: DEPT <180 l / min
In stable condition and without bulk
Good understanding and cognition to follow the instructions and to inform the EVA
Affiliated to a Sickness Insurance Plan or entitled
Signed of informed consent
Exclusion Criteria:
Pregnant woman
Person under guardianship
Inability to cooperate and / or communicate
Acute decompensated organ
Patient with following contraindications to mechanical in-exsufflation (MI-E) devices:
pneumothorax
pneumomediastinum
pulmonary emphysema
hemoptysis
pleurisy
nausea
obstructive pulmonary disease or asthma
recent lobectomy of the lung
intracranial pressure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frédéric LOFASO, MD, PhD
Organizational Affiliation
Department of Physiology and Functional Explorations, Raymond Poincaré Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Physiology and Functional Explorations, Raymond Poincaré Hospital
City
Garches
State/Province
Hauts-de-Seine
ZIP/Postal Code
92380
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
We'll reach out to this number within 24 hrs